Emily WinnDeen Email & Phone Number | Experienced scientific strategist with a proven track record for successful technical and business leadership in genomics, oncology, and molecular diagnostics, much of it focused on novel biomarkers and product development for emerging markets. Deep understanding of FDA and CLIA regulations and their impact on business strategy and assay launch. Successful history of identifying, establishing, and supervising product development programs, key corporate partnerships, and cooperative research agreements. Skilled presenter of company profile, technologies, and strategic vision at both public and business-to-business meetings. Extensive experience in negotiation and execution of patent in/out licensing contracts. Able to perform both the business and technical due diligence for evaluation of potential new business acquisitions. Federal-level advisor on Health and Human Services (HHS) committees for Genetics Health and Society (SACGHS) and Clinical Laboratory Improvement Act Committee (CLIAC), and on the Clinical and Laboratory Standards Institute (CLSI) Area Committee for Molecular Methods. Business advisor to San Diego's CONNECT program. Specialties: Molecular diagnostics, personalized medicine, and companion diagnostics. Expertise includes evaluating market trends and new technology, corporate partnering, GMP manufacturing, FDA design control compliance, and strategic planning.

Emily WinnDeen

Experienced scientific strategist with a proven track record for successful technical and business l...
1015 Leroy Street, San Diego, United States

*50 free lookup(s) per month.

No credit card required.

Emily WinnDeen’s Email emily@mercybio.com

Emily WinnDeen’s Phone Numbers

Get EMILY’s Phone Number (For Free)

Social Media

Emily WinnDeen’s Location 1015 Leroy Street, San Diego, United States

Emily WinnDeen’s Current Industry

Not the Emily WinnDeen you were looking for?

Find accurate emails & phone numbers for over 700M professionals.

Work Experience

Mercy Bioanalytics

Senior Vice President (retired)

2019-08-01 00:00:00 - 2023-12-01 00:00:00

Rx Dx Advisors

President (retired)

2009-02-01 00:00:00 - 2022-12-01 00:00:00

Mesa Biotech

Chief Strategy Officer/Advisor

2015-10-01 00:00:00 - 2020-07-01 00:00:00

Altheadx

Vice President, Research Services

2013-06-01 00:00:00 - 2015-04-01 00:00:00

Illumina

Vice President, Diagnostics Development

2010-04-01 00:00:00 - 2011-12-01 00:00:00

Cepheid

Vice President, Genetics and Oncology R&D

2008-02-01 00:00:00 - 2009-02-01 00:00:00

Roche Molecular Systems

Senior Director, Genomics Business

2002-04-01 00:00:00 - 2004-09-01 00:00:00

Celera

Director, SNP R&D

1998-11-01 00:00:00 - 2002-04-01 00:00:00

Oncor

Director, Diagnostics R&D

1996-07-01 00:00:00 - 1998-11-01 00:00:00

Applied Biosystems

Manager, Diagnostics

1989-01-01 00:00:00 - 1996-01-01 00:00:00

Behring Diagnostics

Manager, Clinical Chemistry R&D

1980-01-01 00:00:00 - 1987-01-01 00:00:00

Skills

No Skills Available

Languages

No Languages Available

FAQ About Emily WinnDeen

Emily WinnDeen is located at
1015 Leroy Street, San Diego, United States

Emily WinnDeen is a Experienced scientific strategist with a proven track record for successful technical and business leadership in genomics, oncology, and molecular diagnostics, much of it focused on novel biomarkers and product development for emerging markets. Deep understanding of FDA and CLIA regulations and their impact on business strategy and assay launch. Successful history of identifying, establishing, and supervising product development programs, key corporate partnerships, and cooperative research agreements. Skilled presenter of company profile, technologies, and strategic vision at both public and business-to-business meetings. Extensive experience in negotiation and execution of patent in/out licensing contracts. Able to perform both the business and technical due diligence for evaluation of potential new business acquisitions. Federal-level advisor on Health and Human Services (HHS) committees for Genetics Health and Society (SACGHS) and Clinical Laboratory Improvement Act Committee (CLIAC), and on the Clinical and Laboratory Standards Institute (CLSI) Area Committee for Molecular Methods. Business advisor to San Diego's CONNECT program. Specialties: Molecular diagnostics, personalized medicine, and companion diagnostics. Expertise includes evaluating market trends and new technology, corporate partnering, GMP manufacturing, FDA design control compliance, and strategic planning.

Emily WinnDeen currently works in the

No Languages Available

Emily WinnDeen has prior
experience in the following industries:
Mercy Bioanalytics | Rx Dx Advisors | Mesa Biotech | Altheadx | Illumina | Cepheid | Roche Molecular Systems | Celera | Oncor | Applied Biosystems | Behring Diagnostics

Emily WinnDeen has the following professional experience:
Mercy Bioanalytics | Rx Dx Advisors | Mesa Biotech | Altheadx | Illumina | Cepheid | Roche Molecular Systems | Celera | Oncor | Applied Biosystems | Behring Diagnostics